Provided by Tiger Trade Technology Pte. Ltd.

RxSIGHT, INC.

7.93
+0.31004.07%
Post-market: 7.930.00000.00%16:43 EST
Volume:640.37K
Turnover:5.05M
Market Cap:326.05M
PE:-8.35
High:8.01
Open:7.71
Low:7.59
Close:7.62
52wk High:27.33
52wk Low:6.32
Shares:41.12M
Float Shares:32.44M
Volume Ratio:0.65
T/O Rate:1.97%
Dividend:- -
Dividend Rate:- -
EPS(TTM):-0.9500
EPS(LYR):-0.9533
ROE:-13.99%
ROA:-9.56%
PB:1.18
PE(LYR):-8.32

Loading ...

RxSight new CFO will be ‘well received,’ says Morgan Stanley

TIPRANKS
·
Jan 12

RxSight Q4 revenue rises 10%, beats analyst expectations

Reuters
·
Jan 12

BRIEF-RxSight Says Mark Wilterding Appointed As CFO Effective Jan 11, 2026

Reuters
·
Jan 11

RxSight Inc. Appoints Mark Wilterding as Chief Financial Officer

Reuters
·
Jan 11

Rxsight Q4 Revenue USD 32.6 Million VS. Ibes Estimate USD 28.6 Million

THOMSON REUTERS
·
Jan 11

Rxsight Inc - Mark Wilterding Appointed as CFO Effective Jan 11, 2026

THOMSON REUTERS
·
Jan 11

Press Release: RxSight, Inc. Announces Preliminary Q4 and 2025 Financial Results; New Chief Financial Officer

Dow Jones
·
Jan 11

RxSight Inc. to Present at J.P. Morgan Healthcare Conference

Reuters
·
Jan 03

RxSight Chief Financial Officer Shelley Thunen to Step Down

MT Newswires Live
·
Dec 23, 2025

BRIEF-RxSight, Inc. Announces Chief Financial Officer Transition

Reuters
·
Dec 23, 2025

RxSight CFO Shelley Thunen to Step Down

Reuters
·
Dec 23, 2025

Rxsight, Inc. Announces Chief Financial Officer Transition

THOMSON REUTERS
·
Dec 23, 2025

Rxsight Inc - Announces CFO Shelley Thunen Transitioning From Role

THOMSON REUTERS
·
Dec 23, 2025

Press Release: RxSight, Inc. Announces Chief Financial Officer Transition

Dow Jones
·
Dec 23, 2025

RxSight Inc. Appoints Eric Weinberg as Chief Business Development Officer and Scott Gaines as Chief Customer Officer

Reuters
·
Dec 20, 2025

RxSight, Inc.'s (NASDAQ:RXST) 28% Price Boost Is Out Of Tune With Revenues

Simply Wall St.
·
Dec 12, 2025

Needham Adjusts RxSight Price Target to $14 From $12, Maintains Buy Rating

MT Newswires Live
·
Dec 05, 2025

RxSight Is Maintained at Equal-Weight by Morgan Stanley

Dow Jones
·
Dec 03, 2025

Needham Raises Price Target on RxSight to $12 From $11, Keeps Buy Rating

MT Newswires Live
·
Nov 06, 2025

Analysts Offer Insights on Healthcare Companies: RxSight (RXST) and InMode (INMD)

TIPRANKS
·
Nov 06, 2025